Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline


Brii, co-founded by GlaxoSmithKline (NYSE: GSK) infectious disease veteran Zhi Hong … has dramatically reduced hepatitis B rates in children, the virus still infects adults for life, putting …

Read more